Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcomes After Intravenous Alteplase / Tenecteplase With or Without Shuxuetong Injection in Routine Clinical Practice: A Patient Registry

NCT06018181 is registered in ClinicalTrials.gov with Dongzhimen Hospital, Beijing as lead sponsor.

NCT NCT06018181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06018181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcomes After Intravenous Alteplase / Tenecteplase With or Without Shuxuetong Injection in Routine Clinical Practice: A Patient Registry
Lead sponsor
Dongzhimen Hospital, Beijing
Phase
Observational
Overall status
Completed
Start date
September 28, 2023
Completion date
September 3, 2025
Enrollment
2,408 (actual)
Sites
78

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke, acute